SCHEMBL4421188

SCHEMBL4421188

CC(N)c1nnn[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15337447 1.00
SCHEMBL17476060 0.80
SCHEMBL9252032 0.80
SCHEMBL1680254 0.79
SCHEMBL266223 0.78
SCHEMBL14909327 0.75 TAAR1 (0.41)
SCHEMBL729364 0.75 TAAR1 (0.41)
SCHEMBL7413806 0.75 TAAR1 (0.41)
SCHEMBL263839 0.74
SCHEMBL19443129 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113636931-B Gene coding compound library initial fragment compound and application thereof in synthesis of gene coding compound library 康龙化成(宁波)科技发展有限公司 2024-02-13 CN disclosed
CN-115066423-B PD-L1 antagonist compounds 厦门宝太生物科技股份有限公司 2024-02-02 CN disclosed
EP-3687988-B1 ANTIBACTERIAL COMPOUND AND USES OF SAME BIOMERIEUX SA (FR) 2023-05-03 EP disclosed
CN-115066423-A PD-L1 antagonist compounds 杭州阿诺生物医药科技有限公司 2022-09-16 CN disclosed
CN-113636931-A Gene coding compound library initial head fragment compound and application thereof in synthesis of gene coding compound library 康龙化成(宁波)科技发展有限公司 2021-11-12 CN disclosed
CN-113302175-A Bicyclic compounds 维瓦斯治疗公司 2021-08-24 CN disclosed
WO-2021129584-A1 PD-L1 ANTAGONIST COMPOUND 杭州阿诺生物医药科技有限公司 2021-07-01 WO disclosed
US-10752640-B2 Compounds active towards bromodomains NUEVOLUTION A/S (DK) 2020-08-25 US disclosed
EP-3687988-A1 ANTIBACTERIAL COMPOUND AND USES OF SAME bioMérieux (FR) 2020-08-05 EP disclosed
US-10201525-B2 Tetrazole-substituted arylamides as PX2 and PX2/3 antagonists ROCHE PALO ALTO LLC (US) 2019-02-12 US disclosed
US-20090326220-A1 Tetrazole-Substituted Arylamides as P2X3 and P2X2/3 Antagonists DILLON MICHAEL PATRICK 2009-12-31 US disclosed
US-20080242091-A1 METAL-POLISHING LIQUID AND POLISHING METHOD FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
US-7414068-B2 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them DONGBU HANNONG CHEMICAL CO., LTD. (KR) 2008-08-19 US disclosed
US-20070055081-A1 Processes for production of alpha-aminooxyketones and alpha-hydroxyketones JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2007-03-08 US disclosed
US-20060035948-A1 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them DONGBU HANNONG CHEMICAL CO., LTD. (KR) 2006-02-16 US disclosed
US-5326760-A Aminobutanoic acid compounds having metalloprotease inhibiting properties GLAXO, INC. (US) 1994-07-05 US disclosed
WO-1994000119-A1 AMINOBUTANOIC ACID COMPOUNDS HAVING METALLOPROTEASE INHIBITING PROPERTIES GLAXO INC. (US) 1994-01-06 WO disclosed
EP-0299533-B1 HIGH POTENCY SWEETENING AGENTS THE NUTRASWEET COMPANY (a Delaware corporation) (US) 1993-04-07 EP disclosed
WO-1989000563-A1 HIGH POTENCY SWEETENING AGENTS THE NUTRASWEET COMPANY (US) 1989-01-26 WO disclosed
EP-0299533-A2 High potency sweetening agents THE NUTRASWEET COMPANY (a Delaware corporation) (US) 1989-01-18 EP disclosed